Array Technologies Inc
(NASDAQ: ARRY)

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

10.690 -

-0.410 (-3.69%)
价格区间 10.590 - 11.230   (6.04%)
开盘 11.230
昨收 11.100
买 10.650
买盘 100
卖 10.990
卖盘 500
成交量 4,464,289
成交额 36,909,974
注释 -
数据延迟。最后一次更新13 Feb 2026 05:00.
数据提供商
查看所有活动

关于 Array Technologies

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

Loading Chart...

Please login to view stock data and analysis